InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Gupta Rishi. Director active across 3 companies, notably Verona Pharma plc. In total, 7 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €69.5m. Activity tracked since 22 December 2022. The latest transaction was disclosed on 16 May 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Gupta Rishi is a declarant and serves as a director at Enliven Therapeutics, Inc., Turnstone Biologics Corp. and Verona Pharma plc. The 7 filings on record, all within the recent sampled filings, run from 2022-12-27 to 2025-08-08 and show 0 EUR of buys and 69522844 EUR of sells, with the dominant transaction type being sale.